A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
September 11, 2019
Premier Inc. Projects 4.2 Percent Price Inflation for Pharmaceuticals
Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies.
September 10, 2019
Premier Comments on Home Infusion Payment and Quality Reporting Policies in CY 2020 Home Health Proposed Rule
Premier continues to urge CMS to amend its misguided policy for Medicare coverage of home infusion therapy services.
August 06, 2019
What We’re Watching: August 6, 2019
CMS released the proposed OPPS rule. We're opposed to the posting of negotiated rates, site neutral payments and continuation of the 340B cuts.
August 01, 2019
How Our Health Systems Are Working to Prevent Hospital Drug Shortages
STAT | Premier members discuss how their health systems are working to prevent hospital drug shortages.
July 29, 2019
Statement on the CY 2020 OPPS Proposed Rule
Premier opposes CMS’ continuation of Medicare site-neutral payments that will reduce payment for outpatient clinic visits by 60 percent.
July 23, 2019
Premier’s ProvideGx™ Program to Supply Sodium Bicarbonate Injection to Providers
Premier has partnered with Exela Pharma Sciences to supply sodium bicarbonate injection, a drug that has been in shortage for nearly two years.
July 23, 2019
What We’re Watching: July 23, 2019
The number of Medicare ACOs taking risk has increased to 29 percent.
July 16, 2019
What We’re Watching: July 16, 2019
Last week, Premier announced a collaborative with 10 hospitals to lower preventable maternal and neonatal harm and deaths.
July 11, 2019
Hospitals May Be Paying Less Than Expected for Drugs
A new Premier analysis is showing some promising pricing projections for pharmaceuticals over the next 12 months.
July 02, 2019
Premier’s ProvideGx™ Program to Make the First FDA-Approved Version of Cysteine Hydrochloride Available to Providers
ProvideGx is now supplying cysteine hydrochloride injection to providers, a critical drug for pediatric and adult patients that require total parenteral nutrition.
June 25, 2019
What We’re Watching: June 25, 2019
Premier announced a partnership with Pensiamo Inc. to launch an AI-powered pharmaceutical supply chain solution that was co-developed with UPMC.
June 18, 2019
Premier Submits Comments on FY 2020 SNF Proposed Payment Rule
Premier cautions against possible operational burdens for post-acute providers.
June 18, 2019
Premier Inc. Partners with Pensiamo Inc. and UPMC to Launch AI-Powered Pharmaceutical Supply Chain Solution
New pharmaceutical supply chain solution uses machine learning to monitor market demand signals, predict shortage risk and recommend optimal inventory levels.
June 11, 2019
What We’re Watching: June 11, 2019
The benchmarking and risk-adjustment methodologies for CMS's Direct Contracting model should be released within the next two months.
June 06, 2019
Capitalizing on Retail Pharmacy to Increase Revenue and Drive Outcomes
As providers look to uncover new revenue lines, it’s little surprise that outpatient retail pharmacies are on their minds.
May 21, 2019
Staying on Top of Accreditation & Regulatory Surveys
To adequately prepare for these surveys, providers need to understand new and future regulations, compliance expectations, staff and evaluator competencies, and leadership responsibilities.
May 21, 2019
What We’re Watching: May 21, 2019
ProvideGx is now supplying and ramping up the production of five more critical shortage drugs.
May 20, 2019
Gaining Ground in the Regulatory Battle to Lower Drug Costs
Many health systems are zeroing in on drug spending as a prime target to better manage margins and limit the growth of expenses.
May 16, 2019
2019 USP <800>, <795> and <797> Checklists
Are you ready for USP <800>, <795> and <797>? The anticipated compliance deadline is Dec. 1, 2019. Regulatory bodies are expected to enforce the...
May 15, 2019
Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications
ProvideGx and Fresenius Kabi are collaborating to mitigate national shortages of injectable thiamine, lidocaine, diphenhydramine, hydromorphone and morphine sulfate.
May 15, 2019
Premier’s ProvideGx Enlists Fresenius Kabi to Tackle Drug Shortages
Modern Healthcare | Premier is working with drugmaker Fresenius Kabi to mitigate drug shortages of five injectables.
